Jane Street’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165K Buy
41,700
+23,300
+127% +$117K ﹤0.01% 10312
2025
Q4
$125K Sell
18,400
-18,400
-50% -$129K ﹤0.01% 10060
2025
Q3
$257K Buy
36,800
+12,900
+54% +$89.7K ﹤0.01% 9216
2025
Q2
$146K Buy
+23,900
New +$159K ﹤0.01% 8769
2022
Q1
Sell
-28,100
Closed -$170K 10733
2021
Q4
$170K Buy
28,100
+100
+0.4% +$694 ﹤0.01% 8934
2021
Q3
$170K Buy
+28,000
New +$316K ﹤0.01% 8970
2018
Q4
Sell
-64,400
Closed -$398K 5400
2018
Q3
$398K Buy
64,400
+11,000
+21% +$49.7K ﹤0.01% 3885
2018
Q2
$341K Buy
53,400
+29,500
+123% +$210K ﹤0.01% 3993
2018
Q1
$167K Buy
+23,900
New +$278K ﹤0.01% 4511
2017
Q4
Sell
-10,500
Closed -$125K 4955
2017
Q3
$125K Buy
+10,500
New +$156K ﹤0.01% 4232

Other funds holding MDXG

Jane Street's MDXG Position: Q1 2026 in Review

Jane Street increased its MiMedx Group (MDXG) stake by 103% in Q1 2026, buying an estimated $1.34M and bringing the position to 525,472 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #5018.

Jane Street first reported a position in MDXG in Q3 2013 and has held it in 24 quarters since. The position peaked at $3.71M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Jane Street held 525,472 shares of MiMedx Group worth $2.08M as of Q1 2026.
  • Jane Street bought 266,210 MiMedx Group shares in Q1 2026, an estimated $1.34M.
  • MiMedx Group made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5018 holding.
  • Jane Street first reported a position in MiMedx Group in Q3 2013 and has held it in 24 quarters since.
  • Jane Street's MiMedx Group position peaked at $3.71M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.